Literature DB >> 18385505

Telbivudine versus lamivudine in patients with chronic hepatitis B.

Hans L Tillmann, John G McHutchison.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18385505     DOI: 10.1056/NEJMc080082

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

Review 1.  Antiviral treatment to prevent chronic hepatitis B or C-related hepatocellular carcinoma.

Authors:  Li-Ping Chen; Jun Zhao; Yan Du; Yi-Fang Han; Tong Su; Hong-Wei Zhang; Guang-Wen Cao
Journal:  World J Virol       Date:  2012-12-12

Review 2.  Emerging Role of Interleukin 22 in Hepatitis B Virus Infection: a Double-edged Sword.

Authors:  Wei Gao; Yu-Chen Fan; Ji-Yuan Zhang; Ming-Hua Zheng
Journal:  J Clin Transl Hepatol       Date:  2013-12-15

3.  Baseline prognostic factors and statistic model to predict early virological response in telbivudine-treated patients with chronic hepatitis B.

Authors:  Rui Zhou; Yuan-Ping Zhou; Chun Lin; Hai-Bing Gao; Shui-Wen Huang; Zu-Xiong Huang; Fang Sun; Yong Lin; Dong-Qing Zhang; Qing-Feng Lin; Wen Ao; Chen Pan
Journal:  Hepat Mon       Date:  2013-12-23       Impact factor: 0.660

4.  Telbivudine Reduces Parvovirus B19-Induced Apoptosis in Circulating Angiogenic Cells.

Authors:  Thomas Zobel; C-Thomas Bock; Uwe Kühl; Maria Rohde; Dirk Lassner; Heinz-Peter Schultheiss; Caroline Schmidt-Lucke
Journal:  Viruses       Date:  2019-03-06       Impact factor: 5.048

Review 5.  Potential capacity of interferon-α to eliminate covalently closed circular DNA (cccDNA) in hepatocytes infected with hepatitis B virus.

Authors:  Gang Wang; Jun Guan; Nazif U Khan; Guojun Li; Junwei Shao; Qihui Zhou; Lichen Xu; Chunhong Huang; Jingwen Deng; Haihong Zhu; Zhi Chen
Journal:  Gut Pathog       Date:  2021-04-12       Impact factor: 4.181

6.  Microarray-based genotyping and detection of drug-resistant HBV mutations from 620 Chinese patients with chronic HBV infection.

Authors:  Wenhao Hua; Guanbin Zhang; Shujun Guo; Weijie Li; Lanhua Sun; Guangxin Xiang
Journal:  Braz J Infect Dis       Date:  2015-05-14       Impact factor: 3.257

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.